#USA #Securities Fraud #Berger Montague #Englewood #Zynex Inc.

Legal Advisory for Zynex Investors

Investors holding Zynex, Inc. (NASDAQ: ZYXI) securities have been put on notice by Berger Montague PC regarding a looming class action lawsuit associated with allegations of securities fraud. The deadline for investors to join the action is fast approaching—May 19, 2025. This advisory seeks to inform those who purchased Zynex securities between March 13, 2023, and March 11, 2025, about their legal rights and options.

Background of the Case

Zynex, a medical device company based in Englewood, Colorado, specializes in electrotherapy devices aimed at pain management and rehabilitation. According to the allegations in the filed lawsuit, there are significant concerns about the company's business practices during the defined class period. The complaint centers around several key points:

1. Inflation of Revenue: It has been alleged that Zynex inflated its revenue by shipping products, including electrodes, beyond actual market demand.
2. False Claims: The company reportedly engaged in practices that involved filing false claims, which have drawn scrutiny from various insurers, including Tricare.
3. Potential Fallout: There are concerns regarding the potential adverse consequences Zynex could face, including being removed from insurance networks and incurring penalties from federal authorities due to these alleged infractions.

How to Participate

Investors who believe they might be affected by these developments are encouraged to consider becoming a lead plaintiff in the class action. The lead plaintiff acts on behalf of the entire class and is typically someone who has the highest financial stake in the outcome. Interested individuals must initiate this process by the May 19 deadline to have their voices heard and interests represented in court.

Contact Information

For additional details about your rights or how to proceed, you can reach out to Berger Montague’s Andrew Abramowitz at [email protected] or call (215) 875-3015. Alternatively, Peter Hamner is also available at [email protected].

Importance of Timely Action

It is critical for investors involved to act promptly, as participation in the class action may provide an opportunity for recovery of losses incurred due to potential fraud. Investors can still join the lawsuit, whether they choose to be active participants or prefer to remain as silent class members.

Company Overview

Founded in 1970, Berger Montague has been at the forefront of securities class action litigation for over fifty years. With offices across multiple U.S. cities, including Philadelphia, Minneapolis, and San Francisco, the firm has extensive experience representing individual and institutional investors.

Investors should take immediate steps to assess their involvement in Zynex's recent troubles. Understanding one's legal position can significantly determine the next steps in the process, ensuring that no rights or potential recovery paths are overlooked.

Conclusion

The allegations against Zynex are serious and could have lasting implications for current and future investors. As the class action deadline approaches, it's vital to stay informed and take any necessary actions. Knowledge is power, and those who keep abreast of these developments will be better prepared to defend their interests.

For more information and resources related to this class action, follow the links provided or contact Berger Montague directly.